The University of Chicago Header Logo

Connection

Issam Awad to Humans

Back to Details
This is a "connection" page, showing publications Issam Awad has written about Humans.
Issam Awad
Connection Strength
1.912
Humans
  1. Intracerebral Hemorrhage: Keep It Simple. Stroke. 2024 Dec; 55(12):2942-2945.
    View in: PubMed
    Score: 0.031
  2. Transcriptomic signatures of individual cell types in cerebral cavernous malformation. Cell Commun Signal. 2024 01 09; 22(1):23.
    View in: PubMed
    Score: 0.030
  3. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke. 2024 01; 55(1):31-39.
    View in: PubMed
    Score: 0.030
  4. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome. Stroke. 2024 01; 55(1):22-30.
    View in: PubMed
    Score: 0.030
  5. Computer-Supervised EVD Raises Safety Questions in ICU Care of IVH: Humans-1, Computers-0. JAMA Netw Open. 2023 10 02; 6(10):e2335184.
    View in: PubMed
    Score: 0.029
  6. Impact of socioeconomics and race on clinical follow-up and trial enrollment and adherence in cerebral cavernous malformation. J Stroke Cerebrovasc Dis. 2023 Jul; 32(7):107167.
    View in: PubMed
    Score: 0.028
  7. Credulity of exploratory trials for cerebral cavernous malformations. Lancet Neurol. 2023 01; 22(1):2-3.
    View in: PubMed
    Score: 0.027
  8. Propranolol as therapy for cerebral cavernous malformations: a cautionary note. J Transl Med. 2022 04 05; 20(1):160.
    View in: PubMed
    Score: 0.026
  9. Commentary: Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases. Neurosurgery. 2021 09 15; 89(4):E207-E208.
    View in: PubMed
    Score: 0.025
  10. In Reply: Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 09 15; 89(4):E247-E248.
    View in: PubMed
    Score: 0.025
  11. COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106101.
    View in: PubMed
    Score: 0.025
  12. Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
    View in: PubMed
    Score: 0.025
  13. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
    View in: PubMed
    Score: 0.024
  14. In Reply: Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2020 04 01; 86(4):E411.
    View in: PubMed
    Score: 0.023
  15. Surgery for intracerebral haemorrhage - Authors' reply. Lancet. 2019 08 24; 394(10199):e22-e23.
    View in: PubMed
    Score: 0.022
  16. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168.
    View in: PubMed
    Score: 0.022
  17. Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268.
    View in: PubMed
    Score: 0.021
  18. Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening. J Neurosurg. 2018 10; 129(4):954-960.
    View in: PubMed
    Score: 0.019
  19. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866.
    View in: PubMed
    Score: 0.019
  20. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
    View in: PubMed
    Score: 0.019
  21. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018 04; 47(4):1133-1138.
    View in: PubMed
    Score: 0.019
  22. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. J Neurosurg. 2017 Jul; 127(1):102-110.
    View in: PubMed
    Score: 0.018
  23. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol. 2016 Jul; 37(7):1209-15.
    View in: PubMed
    Score: 0.017
  24. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016; 10(3):255-64.
    View in: PubMed
    Score: 0.017
  25. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1632-9.
    View in: PubMed
    Score: 0.016
  26. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015 Mar; 17(3):188-196.
    View in: PubMed
    Score: 0.015
  27. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014 Jul 15; 272(1-2):67-75.
    View in: PubMed
    Score: 0.015
  28. Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. Neurosurgery. 2014 Feb; 74 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.015
  29. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014 Feb; 45(2):598-601.
    View in: PubMed
    Score: 0.015
  30. Intensive care after elective craniotomy: "all politics is local". World Neurosurg. 2014 Jan; 81(1):64-5.
    View in: PubMed
    Score: 0.014
  31. Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep. 2012 Dec; 14(6):754-60.
    View in: PubMed
    Score: 0.014
  32. When blood tickles the brain: where is the argument? World Neurosurg. 2013 May-Jun; 79(5-6):636-7.
    View in: PubMed
    Score: 0.014
  33. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4.
    View in: PubMed
    Score: 0.013
  34. External ventricular drainage for intraventricular hemorrhage. Curr Neurol Neurosci Rep. 2012 Feb; 12(1):24-33.
    View in: PubMed
    Score: 0.013
  35. A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective? Hematol Oncol Stem Cell Ther. 2012; 5(1):36-41.
    View in: PubMed
    Score: 0.013
  36. Fenestration of supraclinoid internal carotid artery and associated aneurysm: embryogenesis, recognition, and management. World Neurosurg. 2011 Dec; 76(6):592.e1-5.
    View in: PubMed
    Score: 0.013
  37. Cavernous malformations. J Neurosurg. 2012 Jan; 116(1):119-20; discussion 121.
    View in: PubMed
    Score: 0.013
  38. A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci. 2011 Jun; 18(6):846-8.
    View in: PubMed
    Score: 0.012
  39. Fatal "hypertensive" intracerebral hemorrhage associated with a cerebral cavernous angioma: case report. Acta Neurochir (Wien). 2011 Feb; 153(2):421-3.
    View in: PubMed
    Score: 0.012
  40. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus. 2010 Sep; 29(3):E4.
    View in: PubMed
    Score: 0.012
  41. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus. 2010 Sep; 29(3):E6.
    View in: PubMed
    Score: 0.012
  42. From mutant mice to "vascular permeability therapy" in cavernous angiomas? Neurosurgery. 2009 May; 64(5):N10.
    View in: PubMed
    Score: 0.011
  43. Episteme and the marvelous continuum in neurosurgical science. Neurosurgery. 2009 Apr; 64(4):N10.
    View in: PubMed
    Score: 0.011
  44. Immune response in human cerebral cavernous malformations. Stroke. 2009 May; 40(5):1659-65.
    View in: PubMed
    Score: 0.011
  45. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery. 2009 Mar; 64(3):436-45; discussion 445-6.
    View in: PubMed
    Score: 0.011
  46. Engineering the ideal bypass graft. Neurosurgery. 2008 Oct; 63(4):N9.
    View in: PubMed
    Score: 0.010
  47. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery. 2008 Oct; 63(4):782-9; discussion 789.
    View in: PubMed
    Score: 0.010
  48. Surrogate measures of outcome in clinical trials: clues worth examining? Neurosurgery. 2008 Aug; 63(2):N5.
    View in: PubMed
    Score: 0.010
  49. Neurosurgery and big science. Neurosurgery. 2008 Jun; 62(6):N6.
    View in: PubMed
    Score: 0.010
  50. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg. 2007 Nov; 107(5):1023-6.
    View in: PubMed
    Score: 0.010
  51. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations. Neurosurgery. 2007 Oct; 61(4):693-702; discussion 702-3.
    View in: PubMed
    Score: 0.010
  52. On COURAGE and lessons from the heart. Neurosurgery. 2007 Jun; 60(6):N8.
    View in: PubMed
    Score: 0.009
  53. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2006 Dec; 59(6):1278-84; discussion 1284-5.
    View in: PubMed
    Score: 0.009
  54. Cerebral cavernous malformations: clinical insights from genetic studies. Neurosurg Focus. 2006 Jul 15; 21(1):e1.
    View in: PubMed
    Score: 0.009
  55. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006 Jul 15; 21(1):e7.
    View in: PubMed
    Score: 0.009
  56. Unfolding knowledge on cerebral cavernous malformations. Surg Neurol. 2005 Apr; 63(4):317-8.
    View in: PubMed
    Score: 0.008
  57. Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg Neurol. 2005 Apr; 63(4):319-28; discussion 328.
    View in: PubMed
    Score: 0.008
  58. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke. 2005 Apr; 36(4):872-4.
    View in: PubMed
    Score: 0.008
  59. Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations. Neurosurgery. 2005 Feb; 56(2):343-54.
    View in: PubMed
    Score: 0.008
  60. Multiple spinal cavernous malformations with atypical phenotype after prior irradiation: case report. Neurosurgery. 2004 Dec; 55(6):1431.
    View in: PubMed
    Score: 0.008
  61. Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations. EMBO Mol Med. 2024 Nov; 16(11):2827-2855.
    View in: PubMed
    Score: 0.008
  62. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. J Neurol Neurosurg Psychiatry. 2024 Sep 17; 95(10):892-898.
    View in: PubMed
    Score: 0.008
  63. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 Aug 27; 9(4):446-456.
    View in: PubMed
    Score: 0.008
  64. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery. 2004 Jul; 55(1):1-16; discussion 16-7.
    View in: PubMed
    Score: 0.008
  65. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arterioscler Thromb Vasc Biol. 2024 06; 44(6):1246-1264.
    View in: PubMed
    Score: 0.008
  66. Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis. 2024 Jul; 33(7):107699.
    View in: PubMed
    Score: 0.008
  67. Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis. J Am Heart Assoc. 2024 Mar 19; 13(6):e032910.
    View in: PubMed
    Score: 0.007
  68. Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 Mar; 55(3):541-547.
    View in: PubMed
    Score: 0.007
  69. What genes can teach us about human cerebrovascular malformations. Clin Neurosurg. 2004; 51:140-52.
    View in: PubMed
    Score: 0.007
  70. Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III. Neurocrit Care. 2024 Jun; 40(3):1140-1150.
    View in: PubMed
    Score: 0.007
  71. Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations. Nat Commun. 2023 11 02; 14(1):7009.
    View in: PubMed
    Score: 0.007
  72. mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice. Stroke. 2023 11; 54(11):2906-2917.
    View in: PubMed
    Score: 0.007
  73. Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial. Neurosurgery. 2024 02 01; 94(2):334-339.
    View in: PubMed
    Score: 0.007
  74. Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial. Neurology. 2023 10 17; 101(16):e1614-e1622.
    View in: PubMed
    Score: 0.007
  75. Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
    View in: PubMed
    Score: 0.007
  76. Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Vasc Med. 2023 04; 28(2):153-165.
    View in: PubMed
    Score: 0.007
  77. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003 Feb; 52(2):465-77; discussion 477-8.
    View in: PubMed
    Score: 0.007
  78. ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
    View in: PubMed
    Score: 0.007
  79. Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices. J Stroke Cerebrovasc Dis. 2022 Dec; 31(12):106845.
    View in: PubMed
    Score: 0.007
  80. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol. 2022 09 01; 79(9):856-868.
    View in: PubMed
    Score: 0.007
  81. Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease. Transl Stroke Res. 2023 08; 14(4):513-529.
    View in: PubMed
    Score: 0.007
  82. Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. Stroke. 2022 09; 53(9):2876-2886.
    View in: PubMed
    Score: 0.007
  83. Bayesian deep learning outperforms clinical trial estimators of intracerebral and intraventricular hemorrhage volume. J Neuroimaging. 2022 09; 32(5):968-976.
    View in: PubMed
    Score: 0.007
  84. Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circ Res. 2022 04 15; 130(8):1204-1229.
    View in: PubMed
    Score: 0.007
  85. Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. Stroke. 2022 06; 53(6):1847-1853.
    View in: PubMed
    Score: 0.006
  86. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery. 2002 Jan; 50(1):110-5; discussion 115-6.
    View in: PubMed
    Score: 0.006
  87. Ode to meaning and relevance. Clin Neurosurg. 2002; 49:7-18.
    View in: PubMed
    Score: 0.006
  88. Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials. Neurology. 2022 03 08; 98(10):e1013-e1020.
    View in: PubMed
    Score: 0.006
  89. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Netw Open. 2021 12 01; 4(12):e2135773.
    View in: PubMed
    Score: 0.006
  90. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. J Magn Reson Imaging. 2022 05; 55(5):1440-1449.
    View in: PubMed
    Score: 0.006
  91. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
    View in: PubMed
    Score: 0.006
  92. Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106082.
    View in: PubMed
    Score: 0.006
  93. Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery. 2001 Sep; 49(3):671-9; discussion 679-80.
    View in: PubMed
    Score: 0.006
  94. CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial. J Neuroinflammation. 2021 Aug 21; 18(1):179.
    View in: PubMed
    Score: 0.006
  95. Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation. J Clin Invest. 2021 07 01; 131(13).
    View in: PubMed
    Score: 0.006
  96. Cerebral Cavernous Malformation: From Mechanism to Therapy. Circ Res. 2021 06 25; 129(1):195-215.
    View in: PubMed
    Score: 0.006
  97. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
    View in: PubMed
    Score: 0.006
  98. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021 06; 594(7862):271-276.
    View in: PubMed
    Score: 0.006
  99. Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 04 15; 88(5):961-970.
    View in: PubMed
    Score: 0.006
  100. Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.006
  101. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage. Sci Immunol. 2021 02 19; 6(56).
    View in: PubMed
    Score: 0.006
  102. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery. 2001 Feb; 48(2):359-67; discussion 367-8.
    View in: PubMed
    Score: 0.006
  103. Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
    View in: PubMed
    Score: 0.006
  104. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
    View in: PubMed
    Score: 0.006
  105. Thrombolysis for Evacuation of Intracerebral and Intraventricular Hemorrhage: A Guide to Surgical Protocols With Practical Lessons Learned From the MISTIE and CLEAR Trials. Oper Neurosurg (Hagerstown). 2020 12 15; 20(1):98-108.
    View in: PubMed
    Score: 0.006
  106. A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. JAMA Neurol. 2020 Nov 01; 77(11):1390-1397.
    View in: PubMed
    Score: 0.006
  107. Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury. Neurocrit Care. 2021 06; 34(3):918-926.
    View in: PubMed
    Score: 0.006
  108. Relationship of White Matter Lesions with Intracerebral Hemorrhage Expansion and Functional Outcome: MISTIE II and CLEAR III. Neurocrit Care. 2020 10; 33(2):516-524.
    View in: PubMed
    Score: 0.006
  109. Intraoperative endovascular treatment as an adjunct to microsurgical clipping of paraclinoid aneurysms. J Neurosurg. 2000 Oct; 93(4):554-60.
    View in: PubMed
    Score: 0.006
  110. Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution. J Neurosurg. 2000 Oct; 93(4):569-80.
    View in: PubMed
    Score: 0.006
  111. 3D Deep Neural Network Segmentation of Intracerebral Hemorrhage: Development and Validation for Clinical Trials. Neuroinformatics. 2021 07; 19(3):403-415.
    View in: PubMed
    Score: 0.006
  112. Role of Temporal Sequence in Treating Intracerebral Hemorrhage. Ann Neurol. 2020 08; 88(2):237-238.
    View in: PubMed
    Score: 0.006
  113. Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation. Geroscience. 2020 10; 42(5):1351-1363.
    View in: PubMed
    Score: 0.006
  114. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
    View in: PubMed
    Score: 0.006
  115. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu. J Autoimmun. 2020 09; 113:102469.
    View in: PubMed
    Score: 0.006
  116. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance. J Neurosurg. 2021 03 01; 134(3):1147-1154.
    View in: PubMed
    Score: 0.006
  117. Carotid endarterectomy prevention strategies and complications management. Neurosurg Clin N Am. 2000 Apr; 11(2):351-64.
    View in: PubMed
    Score: 0.006
  118. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
    View in: PubMed
    Score: 0.006
  119. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020 04 01; 48(4):E12.
    View in: PubMed
    Score: 0.006
  120. Primary intraventricular hemorrhage outcomes in the CLEAR III trial. Int J Stroke. 2020 10; 15(8):872-880.
    View in: PubMed
    Score: 0.006
  121. Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation. Int J Mol Sci. 2020 Jan 20; 21(2).
    View in: PubMed
    Score: 0.006
  122. Symptomatic Brain Hemorrhages from Cavernous Angioma After Botulinum Toxin Injections, a Role of TLR/MEKK3 Mechanism? Case Report and Review of the Literature. World Neurosurg. 2020 Apr; 136:7-11.
    View in: PubMed
    Score: 0.006
  123. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery. 2000 Jan; 46(1):28-35; discussion 35-6.
    View in: PubMed
    Score: 0.006
  124. Therapeutic carotid occlusion: current management paradigms. Clin Neurosurg. 2000; 46:363-91.
    View in: PubMed
    Score: 0.006
  125. Which aneurysms should be referred for endovascular therapy? Clin Neurosurg. 2000; 47:188-220.
    View in: PubMed
    Score: 0.006
  126. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
    View in: PubMed
    Score: 0.006
  127. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. Sci Transl Med. 2019 11 27; 11(520).
    View in: PubMed
    Score: 0.006
  128. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. Crit Care Med. 2019 08; 47(8):1125-1134.
    View in: PubMed
    Score: 0.005
  129. Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight. 2019 06 20; 4(12).
    View in: PubMed
    Score: 0.005
  130. Research Update in Neuroscience for Neurosurgeons: a historical perspective. J Neurosurg. 2019 08 01; 131(2):639-648.
    View in: PubMed
    Score: 0.005
  131. A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis. Nat Commun. 2019 04 17; 10(1):1791.
    View in: PubMed
    Score: 0.005
  132. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554.
    View in: PubMed
    Score: 0.005
  133. De novo development of a cavernous malformation of the spinal cord following spinal axis radiation. Case report. J Neurosurg. 1999 Apr; 90(2 Suppl):234-8.
    View in: PubMed
    Score: 0.005
  134. Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH). Neurosurgery. 2019 04 01; 84(4):954-964.
    View in: PubMed
    Score: 0.005
  135. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
    View in: PubMed
    Score: 0.005
  136. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery. 1999 Feb; 44(2):280-7; discussion 287-8.
    View in: PubMed
    Score: 0.005
  137. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
    View in: PubMed
    Score: 0.005
  138. Protocols and critical pathways for stroke care. Clin Neurosurg. 1999; 45:86-100.
    View in: PubMed
    Score: 0.005
  139. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood. 2019 01 17; 133(3):193-204.
    View in: PubMed
    Score: 0.005
  140. Endothelial cell culture from human cerebral cavernous malformations. Stroke. 1998 Nov; 29(11):2426-34.
    View in: PubMed
    Score: 0.005
  141. Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage. Neurocrit Care. 2018 10; 29(2):180-188.
    View in: PubMed
    Score: 0.005
  142. Combined petrosal approach. Curr Opin Otolaryngol Head Neck Surg. 2018 Oct; 26(5):293-301.
    View in: PubMed
    Score: 0.005
  143. The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation. FASEB J. 2019 02; 33(2):2132-2143.
    View in: PubMed
    Score: 0.005
  144. Occipital lobe vascular malformations: prevalence of visual field deficits and prognosis after therapeutic intervention. Neurosurgery. 1998 Sep; 43(3):415-21; discussion 421-3.
    View in: PubMed
    Score: 0.005
  145. Surgery for intracerebral hemorrhage. Neurology. 1998 Sep; 51(3 Suppl 3):S69-73.
    View in: PubMed
    Score: 0.005
  146. Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Surg Neurol. 1998 Aug; 50(2):147-55; discussion 155-6.
    View in: PubMed
    Score: 0.005
  147. The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32.
    View in: PubMed
    Score: 0.005
  148. Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest. 2019 03; 99(3):319-330.
    View in: PubMed
    Score: 0.005
  149. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
    View in: PubMed
    Score: 0.005
  150. Neurologic surgery. J Am Coll Surg. 1998 Feb; 186(2):174-80.
    View in: PubMed
    Score: 0.005
  151. Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med. 2017 Nov 06; 214(11):3331-3346.
    View in: PubMed
    Score: 0.005
  152. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10; 89(15):1553-1560.
    View in: PubMed
    Score: 0.005
  153. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology. 2017 Jul 25; 89(4):355-362.
    View in: PubMed
    Score: 0.005
  154. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke. 1997 Jun; 28(6):1130-7.
    View in: PubMed
    Score: 0.005
  155. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017 05 18; 545(7654):305-310.
    View in: PubMed
    Score: 0.005
  156. Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 2017; 43(5-6):223-230.
    View in: PubMed
    Score: 0.005
  157. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611.
    View in: PubMed
    Score: 0.005
  158. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237.
    View in: PubMed
    Score: 0.004
  159. Endovascular therapeutic approach to peripheral aneurysms of the superior cerebellar artery. AJNR Am J Neuroradiol. 1996 Aug; 17(7):1338-42.
    View in: PubMed
    Score: 0.004
  160. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery. 1996 Jun; 38(6):1265-71.
    View in: PubMed
    Score: 0.004
  161. Giant aneurysms of the anterior circle of Willis: management outcome of open microsurgical treatment. Surg Neurol. 1996 May; 45(5):409-20; discussion 420-1.
    View in: PubMed
    Score: 0.004
  162. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016 Apr 07; 532(7597):122-6.
    View in: PubMed
    Score: 0.004
  163. Innovation through minimalism: assessing emerging technology in neurosurgery. Clin Neurosurg. 1996; 43:303-16.
    View in: PubMed
    Score: 0.004
  164. Galen's anecdote of the fallen sophist: on the certainty of science through anatomy. J Neurosurg. 1995 Nov; 83(5):929-32.
    View in: PubMed
    Score: 0.004
  165. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
    View in: PubMed
    Score: 0.004
  166. Intracarotid amobarbital procedure as a predictor of material-specific memory change after anterior temporal lobectomy. Epilepsia. 1995 Sep; 36(9):857-65.
    View in: PubMed
    Score: 0.004
  167. Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke. 2015 Sep; 46(9):2470-6.
    View in: PubMed
    Score: 0.004
  168. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6620-4.
    View in: PubMed
    Score: 0.004
  169. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301.
    View in: PubMed
    Score: 0.004
  170. Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care. 2014 Dec; 21(3):426-34.
    View in: PubMed
    Score: 0.004
  171. Subarachnoid hemorrhage and choir singing. J Neurosurg. 1994 Jul; 81(1):159-60.
    View in: PubMed
    Score: 0.004
  172. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014 Jul; 49(7):498-504.
    View in: PubMed
    Score: 0.004
  173. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet. 2014 Aug 15; 23(16):4357-70.
    View in: PubMed
    Score: 0.004
  174. Intracranial hypertension after resection of cerebral arteriovenous malformations. Predisposing factors and management strategy. Stroke. 1994 Mar; 25(3):611-20.
    View in: PubMed
    Score: 0.004
  175. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 May; 45(5):1545-88.
    View in: PubMed
    Score: 0.004
  176. DBS reduced hemichorea associated with a developmental venous anomaly and microbleeding in STN. Neurology. 2014 Feb 18; 82(7):636-7.
    View in: PubMed
    Score: 0.004
  177. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia. 1994; 35 Suppl 6:S30-43.
    View in: PubMed
    Score: 0.004
  178. Radiosurgery and venous malformations. J Neurosurg. 1994 Jan; 80(1):171-3; author reply 174-5.
    View in: PubMed
    Score: 0.004
  179. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain. Observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke. 1993 Sep; 24(9):1339-46.
    View in: PubMed
    Score: 0.004
  180. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
    View in: PubMed
    Score: 0.004
  181. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
    View in: PubMed
    Score: 0.004
  182. Giant aneurysms of the proximal anterior cerebral artery: report of three cases. Neurosurgery. 1993 Jul; 33(1):120-4; discussion 124-5.
    View in: PubMed
    Score: 0.004
  183. Hemorrhagic stroke: introduction. Stroke. 2013 Jun; 44(6 Suppl 1):S65-6.
    View in: PubMed
    Score: 0.004
  184. Surgical trials in intracerebral hemorrhage. Stroke. 2013 Jun; 44(6 Suppl 1):S79-82.
    View in: PubMed
    Score: 0.004
  185. Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery. 1993 May; 32(5):876-8.
    View in: PubMed
    Score: 0.004
  186. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34.
    View in: PubMed
    Score: 0.003
  187. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41.
    View in: PubMed
    Score: 0.003
  188. Application of magnetic resonance angiography to neurosurgical practice: a critical review of 150 cases. Neurol Res. 1992 Dec; 14(5):360-8.
    View in: PubMed
    Score: 0.003
  189. Intensive care management of acute hemorrhagic leukoencephalitis with favorable neurologic outcome. Cleve Clin J Med. 1992 Sep-Oct; 59(5):549-52.
    View in: PubMed
    Score: 0.003
  190. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.003
  191. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
    View in: PubMed
    Score: 0.003
  192. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8.
    View in: PubMed
    Score: 0.003
  193. Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg. 2013 Jul-Aug; 80(1-2):89-93.
    View in: PubMed
    Score: 0.003
  194. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
    View in: PubMed
    Score: 0.003
  195. Subdural electrodes in the presurgical evaluation for surgery of epilepsy. Epilepsy Res Suppl. 1992; 5:147-56.
    View in: PubMed
    Score: 0.003
  196. Reoperation for intractable seizures. Clin Neurosurg. 1992; 39:125-39.
    View in: PubMed
    Score: 0.003
  197. Epilepsy surgery: introduction and overview. Clin Neurosurg. 1992; 38:493-513.
    View in: PubMed
    Score: 0.003
  198. MRI-guided stereotactic placement of depth electrodes in temporal lobe epilepsy. Br J Neurosurg. 1992; 6(1):47-53.
    View in: PubMed
    Score: 0.003
  199. Management of incidental cavernous malformations: a review. Neurosurg Focus. 2011 Dec; 31(6):E5.
    View in: PubMed
    Score: 0.003
  200. A new class of electrodes of 'intermediate invasiveness': preliminary experience with epidural pegs and foramen ovale electrodes in the mapping of seizure foci. Neurol Res. 1991 Sep; 13(3):177-83.
    View in: PubMed
    Score: 0.003
  201. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
    View in: PubMed
    Score: 0.003
  202. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. Genet Med. 2011 Jul; 13(7):662-6.
    View in: PubMed
    Score: 0.003
  203. Perioperative management and outcome after surgical treatment of anterior cerebral artery aneurysms. Can J Neurol Sci. 1991 May; 18(2):120-5.
    View in: PubMed
    Score: 0.003
  204. Second operation after the failure of previous resection for epilepsy. Neurosurgery. 1991 Apr; 28(4):510-8.
    View in: PubMed
    Score: 0.003
  205. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011 Mar; 68(3):641-7; discussion 647-8.
    View in: PubMed
    Score: 0.003
  206. Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia. 1991 Mar-Apr; 32(2):179-86.
    View in: PubMed
    Score: 0.003
  207. Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report. Neurosurgery. 2011 Feb; 68(2):E581-6; discussion E586.
    View in: PubMed
    Score: 0.003
  208. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet. 2011 Jan 15; 20(2):211-22.
    View in: PubMed
    Score: 0.003
  209. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.003
  210. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990 Jun; 72(6):839-50.
    View in: PubMed
    Score: 0.003
  211. Neurological deterioration in a patient with a spinal arteriovenous malformation following lumbar puncture. Case report. J Neurosurg. 1990 Apr; 72(4):650-3.
    View in: PubMed
    Score: 0.003
  212. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010 Apr 12; 207(4):881-96.
    View in: PubMed
    Score: 0.003
  213. Intraoperative determination of the extent of corpus callosotomy for epilepsy: two simple techniques. Neurosurgery. 1990 Jan; 26(1):102-5; discussion 105-6.
    View in: PubMed
    Score: 0.003
  214. Alcohol histories in hospital: does the age and sex of the patient make a difference? Br J Addict. 1990 Jan; 85(1):149-50.
    View in: PubMed
    Score: 0.003
  215. Extent of resection in temporal lobectomy for epilepsy. I. Interobserver analysis and correlation with seizure outcome. Epilepsia. 1989 Nov-Dec; 30(6):756-62.
    View in: PubMed
    Score: 0.003
  216. Biology of vascular malformations of the brain. Stroke. 2009 Dec; 40(12):e694-702.
    View in: PubMed
    Score: 0.003
  217. Internal carotid artery occlusion for cavernous segment aneurysm. Neurosurgery. 1989 Sep; 25(3):398-404.
    View in: PubMed
    Score: 0.003
  218. Cavernous malformations of the basal ganglia and thalamus. Neurosurgery. 2009 Jul; 65(1):7-18; discussion 18-9.
    View in: PubMed
    Score: 0.003
  219. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery. 2009 Jul; 65(1):138-44; discussion 144-5.
    View in: PubMed
    Score: 0.003
  220. Brainstem cavernous malformations. Neurosurgery. 2009 May; 64(5):E805-18; discussion E818.
    View in: PubMed
    Score: 0.003
  221. Radiosurgery for angiographically occult vascular malformations. Neurosurg Focus. 2009 May; 26(5):E16.
    View in: PubMed
    Score: 0.003
  222. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery. 1989 Apr; 24(4):557-60.
    View in: PubMed
    Score: 0.003
  223. Patch angioplasty in carotid endarterectomy. Advantages, concerns, and controversies. Stroke. 1989 Mar; 20(3):417-22.
    View in: PubMed
    Score: 0.003
  224. Genomics of human intracranial aneurysm wall. Stroke. 2009 Apr; 40(4):1252-61.
    View in: PubMed
    Score: 0.003
  225. Advances in open neurovascular surgery 2007. Stroke. 2009 Jan; 40(1):324-6.
    View in: PubMed
    Score: 0.003
  226. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008 Dec; 39(12):3222-30.
    View in: PubMed
    Score: 0.003
  227. Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block. Br J Anaesth. 2008 Oct; 101(4):549-56.
    View in: PubMed
    Score: 0.003
  228. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105:217-20.
    View in: PubMed
    Score: 0.002
  229. Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts. Neurogenetics. 2008 Feb; 9(1):25-31.
    View in: PubMed
    Score: 0.002
  230. Spread of malignant gliomas. J Neurosurg. 1987 Jun; 66(6):946-7.
    View in: PubMed
    Score: 0.002
  231. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987 Mar-Apr; 18(2):365-72.
    View in: PubMed
    Score: 0.002
  232. Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups. Neurosurgery. 1987 Feb; 20(2):222-7.
    View in: PubMed
    Score: 0.002
  233. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke. 1986 Nov-Dec; 17(6):1084-9.
    View in: PubMed
    Score: 0.002
  234. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986 Nov-Dec; 17(6):1090-7.
    View in: PubMed
    Score: 0.002
  235. Current updates in perioperative management of intracerebral hemorrhage. Neurol Clin. 2006 Nov; 24(4):745-64.
    View in: PubMed
    Score: 0.002
  236. Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study. Neurosurgery. 1986 Oct; 19(4):655-64.
    View in: PubMed
    Score: 0.002
  237. Retrograde suction decompression of giant paraclinoid aneurysms using a No. 7 French balloon-containing guide catheter. Technical note. J Neurosurg. 2006 Sep; 105(3):479-81.
    View in: PubMed
    Score: 0.002
  238. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery. 1986 Aug; 19(2):247-51.
    View in: PubMed
    Score: 0.002
  239. [Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
    View in: PubMed
    Score: 0.002
  240. How frequently should we follow small asymptomatic intracranial aneurysms? Stroke. 2006 Jul; 37(7):1650; author reply 1651.
    View in: PubMed
    Score: 0.002
  241. Focal parenchymal lesions in transient ischemic attacks: correlation of computed tomography and magnetic resonance imaging. Stroke. 1986 May-Jun; 17(3):399-403.
    View in: PubMed
    Score: 0.002
  242. Temporary and permanent occlusion of cervical and cerebral arteries. Neurosurg Clin N Am. 2005 Apr; 16(2):249-56, viii.
    View in: PubMed
    Score: 0.002
  243. Ruptured superior cerebellar artery aneurysm in a child with bilateral fibromuscular hyperplasia of the renal arteries: case report and review of the literature. J Neurosurg. 2005 Apr; 102(3 Suppl):338-41.
    View in: PubMed
    Score: 0.002
  244. Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: technical case report. Neurosurgery. 2005 Mar; 56(3):E626; discussion E626.
    View in: PubMed
    Score: 0.002
  245. Update on current registries and trials of carotid artery angioplasty and stent placement. Neurosurg Focus. 2005 Jan 15; 18(1):e2.
    View in: PubMed
    Score: 0.002
  246. Nocardial osteomyelitis of the spine with epidural spinal cord compression--a case report. Neurosurgery. 1984 Aug; 15(2):254-6.
    View in: PubMed
    Score: 0.002
  247. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984 Apr; 60(4):771-6.
    View in: PubMed
    Score: 0.002
  248. Conversion of an intracranial arterial stenosis to a symptomatic occlusion after EC/IC bypass surgery. Neurosurgery. 1983 Dec; 13(6):734.
    View in: PubMed
    Score: 0.002
  249. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.002
  250. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003 Sep; 34(9):2310-22.
    View in: PubMed
    Score: 0.002
  251. Mutational analysis of 206 families with cavernous malformations. J Neurosurg. 2003 Jul; 99(1):38-43.
    View in: PubMed
    Score: 0.002
  252. Spine patient outcomes research trial. J Neurosurg. 2003 May; 98(5):1150-2.
    View in: PubMed
    Score: 0.002
  253. Intravenous digital subtraction angiography: an index of collateral cerebral blood flow in internal carotid artery occlusion. Stroke. 1982 Jul-Aug; 13(4):469-72.
    View in: PubMed
    Score: 0.002
  254. Correlation of clinical and angiographic findings in brain ischemia with regional cerebral blood flow measured by the xenon inhalation technique. Neurosurgery. 1982 Jul; 11(1 Pt 1):1-5.
    View in: PubMed
    Score: 0.002
  255. Traumatic postsurgical aneurysm of the intracavernous carotid artery: a delayed presentation. Surg Neurol. 1982 Jul; 18(1):54-7.
    View in: PubMed
    Score: 0.002
  256. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke. 2001 Jun; 32(6):1430-42.
    View in: PubMed
    Score: 0.002
  257. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001 Jun; 32(6):1458-71.
    View in: PubMed
    Score: 0.002
  258. Patterns of functional magnetic resonance imaging activation in association with structural lesions in the rolandic region: a classification system. J Neurosurg. 2001 Jun; 94(6):946-54.
    View in: PubMed
    Score: 0.002
  259. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation. 2001 May 29; 103(21):2644-57.
    View in: PubMed
    Score: 0.002
  260. [Genetic factors related to intracranial arteriovenous malformations]. Neurochirurgie. 2001 May; 47(2-3 Pt 2):154-7.
    View in: PubMed
    Score: 0.002
  261. Advances in the genetics of cerebrovascular disease and stroke. Neurology. 2001 Apr 24; 56(8):997-1008.
    View in: PubMed
    Score: 0.002
  262. A quality-of-life instrument for young hemorrhagic stroke patients. Stroke. 2001 Mar; 32(3):687-95.
    View in: PubMed
    Score: 0.002
  263. Case problems conference: Cushing's disease and parasellar aneurysm. Neurosurgery. 2000 Dec; 47(6):1420-9.
    View in: PubMed
    Score: 0.001
  264. Recommendations for the management of patients with unruptured intracranial aneurysms: A Statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000 Nov; 31(11):2742-50.
    View in: PubMed
    Score: 0.001
  265. Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2000 Oct 31; 102(18):2300-8.
    View in: PubMed
    Score: 0.001
  266. Case problems conference: thoracic spinal cord hernia. Neurosurgery. 2000 Jun; 46(6):1408-15.
    View in: PubMed
    Score: 0.001
  267. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000 Jun; 46(6):1454-9.
    View in: PubMed
    Score: 0.001
  268. Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
    View in: PubMed
    Score: 0.001
  269. Resident curriculum guidelines for neurosurgery. Congress of Neurological Surgeons Education Committee. Clin Neurosurg. 2000; 47:589-681.
    View in: PubMed
    Score: 0.001
  270. Hemorrhagic lesion at the tentorial incisura in a patient with facial nevus. Neurosurgery. 1999 Nov; 45(5):1216-21.
    View in: PubMed
    Score: 0.001
  271. Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg. 1999 Oct; 91(4):626-35.
    View in: PubMed
    Score: 0.001
  272. Neonatal galenic arteriovenous malformation. Neurosurgery. 1999 Apr; 44(4):847-54.
    View in: PubMed
    Score: 0.001
  273. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998 Nov; 7(12):1851-8.
    View in: PubMed
    Score: 0.001
  274. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998 Mar; 19(3):477-84.
    View in: PubMed
    Score: 0.001
  275. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J. 1997 Sep; 73(863):557-9.
    View in: PubMed
    Score: 0.001
  276. Subspecialty certification. Surg Neurol. 1997 Apr; 47(4):403-11.
    View in: PubMed
    Score: 0.001
  277. Indications for carotid endarterectomy. Surg Neurol. 1996 Dec; 46(6):540-4.
    View in: PubMed
    Score: 0.001
  278. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol. 1996 Oct; 17(9):1733-42.
    View in: PubMed
    Score: 0.001
  279. Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions. Stroke. 1996 Sep; 27(9):1558-63.
    View in: PubMed
    Score: 0.001
  280. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery. 1996 Sep; 39(3):537-45; discussion 545-7.
    View in: PubMed
    Score: 0.001
  281. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996 May; 38(5):915-24; discussion 924-5.
    View in: PubMed
    Score: 0.001
  282. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996 Apr 11; 334(15):946-51.
    View in: PubMed
    Score: 0.001
  283. Ischemic stroke and intracranial multifocal cerebral arteriopathy in Williams syndrome. J Pediatr. 1995 Jun; 126(6):945-8.
    View in: PubMed
    Score: 0.001
  284. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res. 1995 Feb; 17(1):49-58.
    View in: PubMed
    Score: 0.001
  285. Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. Electroencephalogr Clin Neurophysiol. 1994 Sep; 91(3):179-93.
    View in: PubMed
    Score: 0.001
  286. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr; 191(1):33-9.
    View in: PubMed
    Score: 0.001
  287. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993 Oct; 33(4):547-54; discussion 554-5.
    View in: PubMed
    Score: 0.001
  288. Comparison and spacial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy. Neurol Res. 1993 Jun; 15(3):160-8.
    View in: PubMed
    Score: 0.001
  289. Epilepsy surgery in children and adults. Ann Acad Med Singap. 1993 May; 22(3 Suppl):501-12.
    View in: PubMed
    Score: 0.001
  290. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
    View in: PubMed
    Score: 0.001
  291. Differences of in vitro electrophysiology of hippocampal neurons from epileptic patients with mesiotemporal sclerosis versus structural lesions. Epilepsia. 1992 Jul-Aug; 33(4):601-9.
    View in: PubMed
    Score: 0.001
  292. Multiple vertebral hemangiomas with neurological signs. Case report. J Neurosurg. 1992 Jun; 76(6):1025-8.
    View in: PubMed
    Score: 0.001
  293. Natural history of recurrent seizures after resective surgery for epilepsy. Epilepsia. 1991 Nov-Dec; 32(6):851-6.
    View in: PubMed
    Score: 0.001
  294. Intracarotid amobarbital procedure: I. Prediction of decreased modality-specific memory scores after temporal lobectomy. Epilepsia. 1991 Nov-Dec; 32(6):857-64.
    View in: PubMed
    Score: 0.001
  295. Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
    View in: PubMed
    Score: 0.001
  296. Reversal of a dense, persistent, holohemispheric neurological deficit after an endarterectomy of the carotid artery: case report. Neurosurgery. 1991 Aug; 29(2):261-4.
    View in: PubMed
    Score: 0.001
  297. Extent of mesiobasal resection determines outcome after temporal lobectomy for intractable complex partial seizures. Neurosurgery. 1991 Jul; 29(1):55-60; discussion 60-1.
    View in: PubMed
    Score: 0.001
  298. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  299. Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery. 1991 May; 28(5):639-45.
    View in: PubMed
    Score: 0.001
  300. Surgical management of syringomyelia: a five year experience in the era of magnetic resonance imaging. Neurol Res. 1991 Mar; 13(1):3-9.
    View in: PubMed
    Score: 0.001
  301. Prediction of cognitive change as a function of preoperative ability status among temporal lobectomy patients seen at 6-month follow-up. Neurology. 1991 Mar; 41(3):399-404.
    View in: PubMed
    Score: 0.001
  302. Delayed facial nerve palsy after temporal lobectomy for epilepsy: report of four cases and discussion of possible mechanisms. Neurosurgery. 1991 Mar; 28(3):453-6.
    View in: PubMed
    Score: 0.001
  303. Intractable complex partial seizures associated with occult temporal lobe encephalocele and meningoangiomatosis: a case report. Surg Neurol. 1990 Nov; 34(5):318-22.
    View in: PubMed
    Score: 0.001
  304. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg. 1990 Oct; 73(4):555-9.
    View in: PubMed
    Score: 0.001
  305. Epidural peg electrodes for the presurgical evaluation of intractable epilepsy. Neurosurgery. 1990 Jul; 27(1):113-5.
    View in: PubMed
    Score: 0.001
  306. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990 May; 27(5):474-9.
    View in: PubMed
    Score: 0.001
  307. Extent of resection in temporal lobectomy for epilepsy. II. Memory changes and neurologic complications. Epilepsia. 1989 Nov-Dec; 30(6):763-71.
    View in: PubMed
    Score: 0.001
  308. Periventricular lesions on MRI. Facts and theories. Stroke. 1989 Jul; 20(7):963-7.
    View in: PubMed
    Score: 0.001
  309. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986 Oct; 20(4):502-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.